2011
DOI: 10.1186/2040-2392-2-19
|View full text |Cite
|
Sign up to set email alerts
|

Increased copy number for methylated maternal 15q duplications leads to changes in gene and protein expression in human cortical samples

Abstract: BackgroundDuplication of chromosome 15q11-q13 (dup15q) accounts for approximately 3% of autism cases. Chromosome 15q11-q13 contains imprinted genes necessary for normal mammalian neurodevelopment controlled by a differentially methylated imprinting center (imprinting center of the Prader-Willi locus, PWS-IC). Maternal dup15q occurs as both interstitial duplications and isodicentric chromosome 15. Overexpression of the maternally expressed gene UBE3A is predicted to be the primary cause of the autistic features… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

9
61
1

Year Published

2012
2012
2016
2016

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 71 publications
(74 citation statements)
references
References 47 publications
9
61
1
Order By: Relevance
“…4 It is not difficult to predict that individuals with Prader-Willi syndrome (PWS) and Angelman syndrome (AS) who carry BP1-BP3 deletion are more severely affected than those who carry BP2-BP3 deletion due to haploinsufflciency of the genes within BP1-BP2 region. [5][6][7] However, if BP1-BP2 duplication has pathogenic influence, theoretically it is reasonable to propose the following hypotheses regarding copy number gains involving the proximal region of 15q, such as 15q11.2-q13 interstitial duplications and triplications and supernumerary marker chromosomes 15 [SMC (15)] with variable sizes of the proximal region of 15q: (1) individuals with copy number gains of the BP1-BP3 region derived from either parent of origin should present clinical features due to overdosage of the genes within BP1-BP2 region; (2) individuals with copy number gains of the BP1-BP3 derived from maternal origin should present more severe clinical features than those who carry copy number gains of BP2-BP3 region, as the pathogenic influences should result from both overdosage of the genes within BP1-BP2 region and overexpression of the maternally expressed gene UBE3A [31][32][33] ; and (3) if a SMC(15) contains euchromatic materials derived from BP1-BP2 region only, the individuals carrying the SMC (15) should present variable severities of clinical features depending on the copy numbers of this region, the level of mosaicism, and their distributions. Obviously, further elucidation of the functions of the genes within the BP1-BP2 region will not only reveal the pathogenic effects of the BP1-BP2 deletion or duplication to neurodevelopment but also improve genotype-phenotype correlations for individuals with PWS, AS, and copy number gains of 15q11.2-q13 region.…”
Section: Discussionmentioning
confidence: 99%
“…4 It is not difficult to predict that individuals with Prader-Willi syndrome (PWS) and Angelman syndrome (AS) who carry BP1-BP3 deletion are more severely affected than those who carry BP2-BP3 deletion due to haploinsufflciency of the genes within BP1-BP2 region. [5][6][7] However, if BP1-BP2 duplication has pathogenic influence, theoretically it is reasonable to propose the following hypotheses regarding copy number gains involving the proximal region of 15q, such as 15q11.2-q13 interstitial duplications and triplications and supernumerary marker chromosomes 15 [SMC (15)] with variable sizes of the proximal region of 15q: (1) individuals with copy number gains of the BP1-BP3 region derived from either parent of origin should present clinical features due to overdosage of the genes within BP1-BP2 region; (2) individuals with copy number gains of the BP1-BP3 derived from maternal origin should present more severe clinical features than those who carry copy number gains of BP2-BP3 region, as the pathogenic influences should result from both overdosage of the genes within BP1-BP2 region and overexpression of the maternally expressed gene UBE3A [31][32][33] ; and (3) if a SMC(15) contains euchromatic materials derived from BP1-BP2 region only, the individuals carrying the SMC (15) should present variable severities of clinical features depending on the copy numbers of this region, the level of mosaicism, and their distributions. Obviously, further elucidation of the functions of the genes within the BP1-BP2 region will not only reveal the pathogenic effects of the BP1-BP2 deletion or duplication to neurodevelopment but also improve genotype-phenotype correlations for individuals with PWS, AS, and copy number gains of 15q11.2-q13 region.…”
Section: Discussionmentioning
confidence: 99%
“…GABA receptorb3 (GABARB3) is a putative ASD susceptibility gene [51] whereas 15q duplication (which includes GABARB3) is associated with elevated rates of ASD [52]. Moreover, postmortem samples from ASD patient brains display reductions in GABARB3 levels [3].…”
Section: Gaba Receptorb3mentioning
confidence: 99%
“…Maternally inherited deletion of this gene causes Angelman syndrome. Overexpression of the maternally expressed gene UBE3A is predicted to be the primary cause of the autistic features associated with dup15q [Scoles et al, 2011].…”
Section: Discussionmentioning
confidence: 99%